CARLSBAD, Calif. — When patients with vitiligo see Jessica Shiu, MD, PhD, for the first time, some mention that prior healthcare providers have told them that vitiligo is merely a cosmetic issue — ...

Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an ...

The company advanced its main asset, EB06, which is being developed for the treatment of vitiligo, with key preparations underway for a manufacturing campaign. Edesa anticipates submitting data to the ...

It was found that adding NB-UVB light therapy to ruxolitinib (Opzelura) 1.5% cream helped many vitiligo patients who did not respond early to treatment achieve faster and more noticeable skin ...

Please provide your email address to receive an email when new articles are posted on . Melanocyte keratinocyte transplantation can yield significant repigmentation ranging from 70% to 100%. The ...

ITHACA, NY (WBNG) -- Researchers at Cornell University have made progress on treatment for vitiligo, a skin condition and autoimmune disorder that causes white patches to appear on the skin. Associate ...

Although clinical studies have assessed many treatments for vitiligo, the heterogeneity of these studies makes comparison of the effectiveness of treatments – alone or combined – very difficult.

Please provide your email address to receive an email when new articles are posted on . In the phase 2b trial, 160 subjects will be randomly assigned to receive one of three concentrations of VYN201 ...

Controversy arose after it was revealed that the hospital where actor Ko Yoo-hwan, 45, received treatment for vitiligo was a plastic surgery clinic rather than a dermatology clinic. In response, the ...